Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) EPS (Basic) (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed EPS (Basic) for 16 consecutive years, with -$0.51 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 45.29% to -$0.51 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 through Dec 2025, up 40.39% year-over-year, with the annual reading at -$1.18 for FY2025, 42.97% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.51 at Creative Medical Technology Holdings, down from -$0.48 in the prior quarter.
  • The five-year high for EPS (Basic) was $12.22 in Q1 2021, with the low at -$2.61 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$0.08, with a median of -$0.63 recorded in 2025.
  • Peak annual rise in EPS (Basic) hit 13477.78% in 2021, while the deepest fall reached 12400.0% in 2021.
  • Over 5 years, EPS (Basic) stood at -$2.61 in 2021, then surged by 79.69% to -$0.53 in 2022, then crashed by 125.0% to -$1.19 in 2023, then grew by 21.62% to -$0.93 in 2024, then skyrocketed by 45.29% to -$0.51 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.51, -$0.48, and -$0.48 for Q4 2025, Q3 2025, and Q2 2025 respectively.